Detalhe da pesquisa
1.
The DO-KB Knowledgebase: a 20-year journey developing the disease open science ecosystem.
Nucleic Acids Res
; 52(D1): D1305-D1314, 2024 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37953304
2.
Treatment of secondary CNS lymphoma using CD19-targeted chimeric antigen receptor (CAR) T cells.
Cancer Immunol Immunother
; 73(3): 45, 2024 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38349430
3.
Peripheral blood blast rate of clearance is an independent predictor of clinical response and outcomes in acute myeloid leukaemia.
Br J Haematol
; 188(6): 881-887, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31804722
4.
Immune-mediated facial nerve paralysis in a myeloma patient post B-cell maturation antigen-targeted chimeric antigen receptor T cells.
Haematologica
; 109(2): 682-688, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37675514
5.
Relapsed Philadelphia Chromosome-Positive Pre-B-ALL after CD19-Directed CAR-T Cell Therapy Successfully Treated with Combination of Blinatumomab and Ponatinib.
Acta Haematol
; 141(2): 107-110, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30695783
6.
Photo Quiz: An Elderly Leukemia Patient with Jaw Pain and Swelling and Subjective Fevers.
J Clin Microbiol
; 58(6)2020 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-32457230
7.
Answer to June 2020 Photo Quiz.
J Clin Microbiol
; 58(6)2020 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-32457231
8.
Treatment of CD19-positive mixed phenotype acute leukemia with blinatumomab.
Am J Hematol
; 94(1): E7-E8, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30328137
9.
Rapid relapse of large B-cell lymphoma after CD19 directed CAR-T-cell therapy due to CD-19 antigen loss.
Am J Hematol
; 94(10): E273-E275, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31342556
10.
Refractory postallogeneic stem cell transplant pure red cell aplasia in remission after treatment with daratumumab.
Am J Hematol
; 94(8): E216-E219, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31120638
11.
Breast carcinoma: is molecular evaluation a necessary part of current pathological analysis?
Semin Diagn Pathol
; 30(4): 321-8, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24342288
12.
Fusion Gene-Based Classification of Variant Cytogenetic Rearrangements in Acute Myeloid Leukemia.
Genes (Basel)
; 14(2)2023 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36833323
13.
Myeloid madness: assessing diagnostic inconsistency between the new WHO and ICC schemes for myelodysplastic/myeloproliferative neoplasms.
J Clin Pathol
; 77(1): 68-72, 2023 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37696594
14.
Chimeric antigen receptor (CAR) T cells for the treatment of a kidney transplant patient with post-transplant lymphoproliferative disorder (PTLD).
Hum Vaccin Immunother
; 19(2): 2216116, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37278257
15.
Pathology Trainees Gain Clinical Pathology Experience as Lab Consultants Through Auditing Myeloid Mutation Panel Send-Out Tests: Hitting Two Birds With One Stone?
Arch Pathol Lab Med
; 146(10): 1286-1290, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35089993
16.
Therapy-related B-lymphoblastic leukemia after multiple myeloma.
Leuk Res Rep
; 18: 100358, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36353199
17.
Costimulatory molecule-targeted antibody therapy of a spontaneous autoimmune disease.
Nat Med
; 8(12): 1405-13, 2002 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-12426559
18.
Aspartate ß-Hydroxylase (ASPH) Expression in Acute Myeloid Leukemia: A Potential Novel Therapeutic Target.
Front Oncol
; 11: 783744, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35004304
19.
Coordinate expression and trans presentation of interleukin (IL)-15Ralpha and IL-15 supports natural killer cell and memory CD8+ T cell homeostasis.
J Exp Med
; 200(7): 825-34, 2004 Oct 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-15452177
20.
Interleukin (IL)-15R[alpha]-deficient natural killer cells survive in normal but not IL-15R[alpha]-deficient mice.
J Exp Med
; 197(8): 977-84, 2003 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-12695489